clopidogrel

Generic: clopidogrel

Labeler: camber pharmaceuticals, inc.
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name clopidogrel
Generic Name clopidogrel
Labeler camber pharmaceuticals, inc.
Dosage Form TABLET
Routes
ORAL
Active Ingredients

clopidogrel 75 mg/1

Manufacturer
Camber Pharmaceuticals, Inc.

Identifiers & Regulatory

Product NDC 31722-758
Product ID 31722-758_04d99965-cea0-8e7d-e063-6394a90ab281
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA205345
Listing Expiration 2026-12-31
Marketing Start 2023-08-04

Pharmacologic Class

Established (EPC)
p2y12 platelet inhibitor [epc]
Mechanism of Action
p2y12 receptor antagonists [moa] cytochrome p450 2c8 inhibitors [moa]
Physiologic Effect
decreased platelet aggregation [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 31722758
Hyphenated Format 31722-758

Supplemental Identifiers

RxCUI
309362 749196
UPC
0331722759304 0331722758307
UNII
A74586SNO7
NUI
N0000008832 N0000182142 N0000182143 N0000187062

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name clopidogrel (source: ndc)
Generic Name clopidogrel (source: ndc)
Application Number ANDA205345 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 75 mg/1
source: ndc
Packaging
  • 500 TABLET in 1 BOTTLE (31722-758-05)
  • 30 TABLET in 1 BOTTLE (31722-758-30)
  • 90 TABLET in 1 BOTTLE (31722-758-90)
source: ndc

Packages (3)

31722-758-05 500 TABLET in 1 BOTTLE (31722-758-05) 31722-758-30 30 TABLET in 1 BOTTLE (31722-758-30) 31722-758-90 90 TABLET in 1 BOTTLE (31722-758-90)

Ingredients (1)

clopidogrel (75 mg/1)

Linked Drug Pages (1)

CLOPIDOGREL ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "04d99965-cea0-8e7d-e063-6394a90ab281", "openfda": {"nui": ["N0000008832", "N0000182142", "N0000182143", "N0000187062"], "upc": ["0331722759304", "0331722758307"], "unii": ["A74586SNO7"], "rxcui": ["309362", "749196"], "spl_set_id": ["b573aefa-e337-478f-97e4-eb8472a7e497"], "pharm_class_pe": ["Decreased Platelet Aggregation [PE]"], "pharm_class_epc": ["P2Y12 Platelet Inhibitor [EPC]"], "pharm_class_moa": ["P2Y12 Receptor Antagonists [MoA]", "Cytochrome P450 2C8 Inhibitors [MoA]"], "manufacturer_name": ["Camber Pharmaceuticals, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "500 TABLET in 1 BOTTLE (31722-758-05)", "package_ndc": "31722-758-05", "marketing_start_date": "20230804"}, {"sample": false, "description": "30 TABLET in 1 BOTTLE (31722-758-30)", "package_ndc": "31722-758-30", "marketing_start_date": "20230804"}, {"sample": false, "description": "90 TABLET in 1 BOTTLE (31722-758-90)", "package_ndc": "31722-758-90", "marketing_start_date": "20230804"}], "brand_name": "CLOPIDOGREL", "product_id": "31722-758_04d99965-cea0-8e7d-e063-6394a90ab281", "dosage_form": "TABLET", "pharm_class": ["Cytochrome P450 2C8 Inhibitors [MoA]", "Decreased Platelet Aggregation [PE]", "P2Y12 Platelet Inhibitor [EPC]", "P2Y12 Receptor Antagonists [MoA]"], "product_ndc": "31722-758", "generic_name": "CLOPIDOGREL", "labeler_name": "Camber Pharmaceuticals, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "CLOPIDOGREL", "active_ingredients": [{"name": "CLOPIDOGREL", "strength": "75 mg/1"}], "application_number": "ANDA205345", "marketing_category": "ANDA", "marketing_start_date": "20230804", "listing_expiration_date": "20261231"}